Arista Networks, Inc. (NYSE:ANET) shares moved up 3.84% in last trading session and ended the day at $65.65. ANET Gross Margin is 64.90% and its has a return on assets of 14.00%. Arista Networks, Inc. (NYSE:ANET) quarterly performance is 2.05%.
Arista Networks, Inc. (NYSE:ANET) will release its financial results for the quarter ended March 31, 2016 after U.S. markets close on Thursday, May 5th.
Shaw Communications, Inc. (NYSE:SJR) ended the last trading day at $18.61. Company weekly volatility is calculated as 1.85% and price to cash ratio as 33.17. Shaw Communications, Inc. (NYSE:SJR) showed a weekly performance of 3.22%.
Shaw Communications Inc. (NYSE:SJR) announced that its Board of Directors has declared the quarterly dividend on its Cumulative Redeemable Rate Reset Preferred Shares, Series A (the “Series A Shares”) for the three-month period ended June 30, 2016. The dividend of $0.28125 per Series A Share will be payable on June 30, 2016 to holders of record at the close of business on June 15, 2016.
On 22 April, Carter’s, Inc. (NYSE:CRI) shares moved down -0.18% and was closed at $104.79. CRI EPS growth in last 5 year was 12.80%. Carter’s, Inc. (NYSE:CRI) year to date (YTD) performance is 18.09%.
Carter’s, Inc. (NYSE:CRI), the largest branded marketer in the United States and Canada of apparel exclusively for babies and young children, will report its first quarter fiscal 2016 results before the market opens on Thursday, April 28, 2016.
SciQuest, Inc. (NASDAQ:SQI) shares moved up 0.49% in last trading session and ended the day at $14.42. SQI Gross Margin is 68.10% and its has a return on assets of 0.70%. SciQuest, Inc. (NASDAQ:SQI) quarterly performance is 12.39%.
SciQuest, Inc. (NASDAQ:SQI), the leading public provider of spend management solutions delivering value beyond savings, announced it was selected as a finalist by the World Procurement Awards 2016 in the Procurement Service Provider Award category.
Medgenics, Inc. (NYSEMKT:MDGN) caters to the Healthcare space. Its weekly performance is 5.38%. On the last day of trading company shares ended up at $5.09.
On 20 April, Medgenics, Inc. (NYSEMKT: MDGN) announced the appointment of Eric Phillips, MPH, ScD as Vice President of Regulatory Affairs. In this role, Dr. Phillips will be a key member of the Medgenics leadership team setting the strategy and tactics for all regulatory activities. Dr. Phillips has held positions of increasing responsibility in Regulatory Affairs, most recently at Bristol-Myers Squibb, where he led the successful submission for the approval of Opdivo® in the treatment of squamous non-small cell lung cancer, and the recent submission of the supplemental Biologics License Appilcation for the use of Opdivo in the treatment of Hodgkin lymphoma
Leave a Reply